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Abstract. 
 
Laminin trimers composed of 
 
a
 
, 
 
b
 
, and 
 
g
 
 
chains are major components of basal laminae (BLs) 
throughout the body. To date, three 
 
a
 
 chains (
 
a
 
1–3) 
have been shown to assemble into at least seven het-
erotrimers (called laminins 1–7). Genes encoding two 
additional 
 
a
 
 chains (
 
a
 
4 and 
 
a
 
5) have been cloned, but 
little is known about their expression, and their protein 
products have not been identified. Here we generated 
antisera to recombinant 
 
a
 
4 and 
 
a
 
5 and used them to 
identify authentic proteins in tissue extracts. Immuno-
precipitation and immunoblotting showed that 
 
a
 
4 and 
 
a
 
5 assemble into four novel laminin heterotrimers 
(laminins 8–11: 
 
a
 
4
 
b
 
1
 
g
 
1, 
 
a
 
4
 
b
 
2
 
g
 
1, 
 
a
 
5
 
b
 
1
 
g
 
1, and 
 
a
 
5
 
b
 
2
 
g
 
1, 
respectively). Using a panel of nucleotide and antibody 
probes, we surveyed the expression of 
 
a
 
1-5 in murine 
tissues. All five chains were expressed in both embryos 
and adults, but each was distributed in a distinct pattern 
at both RNA and protein levels. Overall, 
 
a
 
4 and 
 
a
 
5 ex-
hibited the broadest patterns of expression, while ex-
pression of 
 
a
 
1 was the most restricted. Immunohis-
tochemical analysis of kidney, lung, and heart showed 
that the 
 
a
 
 chains were confined to extracellular matrix 
and, with few exceptions, to BLs. All developing and 
adult BLs examined contained at least one 
 
a
 
 chain, all 
 
a
 
 chains were present in multiple BLs, and some BLs 
contained two or three 
 
a
 
 chains. Detailed analysis of 
developing kidney revealed that some individual BLs, 
including those of the tubule and glomerulus, changed 
in laminin chain composition as they matured, express-
ing up to three different 
 
a
 
 chains and two different 
 
b
 
 
chains in an elaborate and dynamic progression. Inter-
specific backcross mapping of the five 
 
a
 
 chain genes re-
vealed that they are distributed on four mouse chromo-
somes. Finally, we identified a novel full-length 
 
a
 
3 
 
isoform encoded by the 
 
Lama3
 
 gene, which was previ-
ously believed to encode only truncated chains. To-
gether, these results reveal remarkable diversity in BL 
composition and complexity in BL development.
 
L
 
aminins
 
 are components of all basal laminae (BLs)
 
1
 
throughout the bodies of vertebrates and inverte-
brates. In mammals they play at least three essen-
tial roles. First, they are major structural elements of BLs,
forming one of two self-assembling networks (the other is
composed of the collagens IV) to which other glycopro-
teins and proteoglycans of the BL attach (for review see
Yurchenco and O’Rear, 1994; Timpl, 1996). Second, they
interact with cell surface components such as dystroglycan
to attach cells to the extracellular matrix (for review see
Henry and Campbell, 1996). Third, they are signaling mol-
ecules that interact with cellular receptors such as the inte-
grins to convey morphogenetically important information
to the cell’s interior (for review see Clark and Brugge,
1995; Mercurio, 1995; Yamada and Miyamoto, 1995). For
example, laminin promotes myogenesis in skeletal muscle,
outgrowth of neurites from central and peripheral neu-
rons, and mesenchymal to epithelial transitions in kidney
(Foster et al., 1987; Klein et al., 1988; Reichardt and To-
maselli, 1991; Vachon et al., 1996).
Laminin was initially isolated from tumor cells as a het-
erotrimer of A, B1, and B2 subunits (Chung et al., 1979;
Timpl et al., 1979), later renamed 
 
a
 
1, 
 
b
 
1, and 
 
g
 
1 (Burge-
son et al., 1994). Molecular cloning revealed that the three
subunits were encoded by distinct but homologous genes
(Martin and Timpl, 1987). Subsequently, homologues of
the 
 
a
 
1 chain (merosin, or 
 
a
 
2; Ehrig et al., 1990) and the 
 
b
 
1
chain (s-laminin, or 
 
b
 
2; Hunter et al., 1989
 
b
 
) were isolated,
revealing a previously unsuspected heterogeneity of lami-
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nins. Five additional laminin chains have now been identi-
fied, all of which clearly belong to the 
 
a
 
, 
 
b
 
, or 
 
g
 
 subfamilies
(
 
a
 
3–5, 
 
b
 
3, and 
 
g
 
2; Kallunki et al., 1992; Ryan et al., 1994;
Aberdam et al., 1994
 
b
 
; Richards et al., 1994; Gerecke et
al., 1994; Miner et al., 1995). All native laminins isolated to
date are composed of one 
 
a
 
, one 
 
b
 
, and one 
 
g
 
 chain, and
seven distinct heterotrimers have been identified (for re-
view see Engvall and Wewer, 1996). The existence of mul-
tiple chains that oligomerize with a defined stoichiometry
provides a means to generate functional diversity within a
common structural framework (Sanes et al., 1990).
Here we focus on the 
 
a
 
 subfamily of laminin chains. This
is the largest subfamily, with five members identified to
date in mammals. Interactions of cells with laminin 
 
a
 
 chains
are critical for cell–matrix interactions. For example, at least
six distinct integrin heterodimers (
 
a
 
1
 
b
 
1, 
 
a
 
2
 
b
 
1, 
 
a
 
3
 
b
 
1, 
 
a
 
6
 
b
 
1,
 
a
 
7
 
b
 
1, and 
 
a
 
v
 
b
 
3), as well as dystroglycan, heparin, and the
adhesion molecule–associated glycoconjugate HNK-1/L2,
bind to sites on laminin 
 
a
 
 chains (Rao and Kefalides, 1990;
Gee et al., 1993; Hall et al., 1993; Sung et al., 1993; Mercu-
rio, 1995; Mecham and Hinek, 1996; Colognato, H., and
P.D. Yurchenco. 1996. 
 
Mol. Biol. Cell.
 
 7(Suppl.):67
 
a
 
). More-
over, both dystroglycan and some integrins can distinguish
amongst different 
 
a
 
 chains, suggesting that 
 
a
 
 chain diver-
sity is functionally significant (Mercurio, 1995; Pall et al.,
1996). In direct support of this notion, mutations in two 
 
a
 
chains, 
 
a
 
2 and 
 
a
 
3, lead to congenital muscular dystrophy
and junctional epidermolysis bullosa, respectively (Sunada
et al., 1994; Xu et al., 1994; Helbling-Leclerc et al., 1995;
McGrath et al., 1995). In 
 
Drosophila
 
, mutation of the only
known laminin 
 
a
 
 chain is embryonically lethal, leading to
defects in numerous tissues (Henchcliffe et al., 1993; Yar-
nitzky and Volk, 1995; Garcia-Alonso et al., 1996).
Despite their importance, limited information is avail-
able about the distribution of the 
 
a
 
 chains (see, e.g., En-
gvall et al., 1990; Sanes et al., 1990; Vuolteenaho et al., 1994;
Virtanen et al., 1995, 1996). Moreover, the 
 
a
 
1 chain has
been studied most intensively in human tissues with a sin-
gle mAb (4C7; Engvall et al., 1986, 1990) whose specificity
for 
 
a
 
1 has been questioned (Ekblom, 1996). For the re-
cently discovered 
 
a
 
4 and 
 
a
 
5 chains, no direct evidence has
been presented to show that they form heterotrimers, and
no data on cellular localization have been reported. Ac-
cordingly, we have generated and characterized antibodies
to the 
 
a
 
4 and 
 
a
 
5 chains and used them to identify four
novel laminin heterotrimers: laminin-8 (
 
a
 
4
 
b
 
1
 
g
 
1), laminin-9
(
 
a
 
4
 
b
 
2
 
g
 
1), laminin-10 (
 
a
 
5
 
b
 
1g1), and laminin-11 (a5b2g1).
Using a panel of antibodies and cDNA probes, we ana-
lyzed the distribution of all five laminin a chains in embry-
onic and adult mice. We show that the a chains are ex-
pressed in overlapping but distinct patterns, with each BL
containing at least one of the known a chains. Moreover,
we demonstrate that some individual BLs contain differ-
ent complements of a chains at distinct stages of their de-
velopment. Finally, we identify a novel isoform of a3 and
report the chromosomal locations of all five a chains in mice.
Materials and Methods
Isolation of cDNAs
Laminin a3B.  We performed the reverse transcription–coupled PCR
(RT-PCR) using embryonic day (E) 17.5 mouse lung RNA and primers de-
signed to amplify sequences encoding the NH2-terminal portion of do-
main VI of laminin a5. Surprisingly, the reaction generated a novel 209-bp
fragment that was similar but not identical to known a chains. We hypoth-
esized that this fragment could be part of a laminin a3B cDNA extending
59 of that reported by Galliano et al. (1995). To test this hypothesis, two
primers were used in RT-PCR from adult lung RNA to attempt to amplify
the potentially intervening cDNA: sense, 59AGCGGGACCCAGA-
GGTC39 (from the novel product); antisense, 59TGCCTCACAGAC-
AATCTCACC39 (from near the 59 end of the sequence in Galliano et al.
[1995]). RT-PCR conditions were as described (Miner and Sanes, 1994),
with the addition of Taq Extender PCR Additive (Stratagene Cloning
Systems, La Jolla, CA). A 2.2-kb fragment was sequenced with a Taq
DyeDeoxy Terminator cycle sequencing kit (Applied Biosystems, Inc.,
Foster City, CA), and sequence was analyzed on the BLAST server at the
National Center for Biotechnology Information (Altschul et al., 1990). Se-
quence was obtained from multiple clones to resolve errors introduced by
Taq polymerase amplification.
Laminin a4.  A mouse laminin a4 cDNA fragment was amplified by
RT-PCR from E17.5 placenta using degenerate primers based on the hu-
man amino acid sequence (Richards et al., 1994). The primers, designed to
amplify the mouse segment homologous to nucleotides 1,800–2,607, were:
sense, 59TCNATGATGTTYGAYGGNCARTC39; antisense, 59CGNCCR-
CTRCTRAANCCRAARTC39. The fragment was isolated on a low melt-
ing point gel and ligated into the pCRII vector (Invitrogen, San Diego,
CA). The DNA and deduced amino acid sequences were determined and
have been deposited into GenBank under accession number U88352.
RNA Analyses
RNA was prepared from mouse tissues by acid guanidinium phenol/chlo-
roform extraction (Chomczynski and Sacchi, 1987). RNase protections
were performed as described (Miner and Wold, 1991) using [32P]UTP-la-
beled probes and 5 mg (E17.5) or 7.5 mg (adult) of total RNA per hybrid-
ization. A probe for elongation factor 1a was included to control for the
quality and amount of input RNA. For Northern analysis, a filter contain-
ing poly(A)-selected RNA from several adult mouse tissues (Clontech,
Palo Alto, CA) was hybridized according to the manufacturer’s instruc-
tions. In situ hybridizations were performed with 35S-UTP–labeled probes
as described (Lentz et al., 1997). The laminin a chain probes used for
RNase protection assays and in situ hybridizations were as described (Lentz
et al., 1997).
Antibodies
Rat mAbs to mouse laminin a1 (clones 198 and 200; Sorokin et al., 1992)
were gifts from Lydia Sorokin (Institute for Experimental Medicine, Er-
langen, Germany). A rabbit antiserum to human laminin a2 cross-reactive
with the mouse protein (Vachon et al., 1996) was kindly provided by Peter
Yurchenco (Robert Wood Johnson Medical School, Piscataway, NJ). A
rabbit antiserum to mouse laminin a3 (Aberdam et al., 1994a,b) was a gift
from Daniel Aberdam (INSERM U385, Nice, France). Mouse mAbs to
rat laminin chains b1 (C21, C22), b2 (D7, D19, D27), and g1 (D18) were
produced and characterized in our laboratory and have been described
previously (Sanes and Chiu, 1983; Hunter et al., 1989b; Sanes et al., 1990;
Green et al., 1992). A guinea pig antiserum against a recombinant COOH-
terminal fragment of laminin b2 was produced as described (Sanes et al.,
1990). A rat mAb to laminin g1 was purchased from Chemicon (Temec-
ula, CA). Second antibodies were purchased as follows: fluorescein- and
HRP-conjugated goat anti–rabbit antibodies from Boehringer Mannheim
Biochemicals (Indianapolis, IN); fluorescein-conjugated goat anti–rat an-
tibodies from Cappel/Organon Teknika (Durham, NC); Cy3-conjugated
goat anti–rabbit antibodies from Jackson ImmunoResearch Laboratories
(West Grove, PA); biotinylated goat anti–guinea pig antibodies from
Sigma Chemical Co. (St. Louis, MO).
To generate antibodies to the laminin a4 and a5 chains, the laminin a4
cDNA described above, another containing nucleotides 3,670–4,391 (de-
scribed in Lentz et al., 1997), and a laminin a5 fragment comprising nucle-
otides 4,243–4,926 (SacI to EcoRV) were each cloned in frame into the
pET 23 vector (Novagen, Madison, WI). Proteins were produced in
BL21(DE3) bacteria, and inclusion bodies were isolated according to a
protocol supplied by Novagen. Fusion proteins were gel isolated as de-
scribed (Miner and Sanes, 1994) and used to immunize rabbits (Caltag,
Healdsburg, CA). For both a4 and a5, two separately immunized rabbits
generated antisera that displayed qualitatively similar patterns of reactiv-Miner et al. The Laminin a Chains 687
ity on both sections and immunoblots. The higher titer antiserum to each
immunogen was used for the studies reported here.
Immunohistochemistry
Mouse tissues were frozen fresh and sectioned at 4–8 mm on a cryostat.
Antibodies were diluted in 1% (wt/vol) BSA in PBS and incubated on sec-
tions for 1–2 h. After rinsing off unbound primary antibody with PBS, sec-
ondary antibodies were applied for 1–2 h. Sections were rinsed again, and
then mounted in glycerol-para-phenylenediamine and observed with epi-
fluorescent illumination. Since the laminin a4 antisera only recognized de-
natured antigen, the following protocol was used when staining with these
antibodies: sections were fixed in 2% paraformaldehyde in PBS for 20
min, rinsed in PBS, incubated with 100 mM glycine in PBS for 10 min, in-
cubated in 0.05% SDS in PBS for 30 min at 508C, and then rinsed in PBS
before the antibody was applied. Anti-a5 stained untreated and SDS-
denatured sections in qualitatively similar patterns.
Western Blots and Immunoprecipitations
For immunoblotting, tissues from rat were used because a greater range of
mAbs was available against rat than against mouse laminin b and g chains
(see above). Lungs and kidneys from saline-perfused adult rats were ho-
mogenized in ice-cold 40 mM Tris, pH 7.5, 15 mM NaCl, and 2 mM CaCl2
(H buffer) containing protease inhibitors (0.1 mM PMSF, 1 mM benzami-
dine, and 1 mg/ml soybean trypsin inhibitor) using a Polytron. Crude mem-
brane fractions were recovered at 20,000 g, washed once with H buffer
containing PMSF, resuspended in H buffer containing 10 mM EDTA, 2
mM EGTA, PMSF, and soybean trypsin inhibitor (H1E buffer), and
stored at 2108C. To improve immunoblotting sensitivity for BL compo-
nents, the crude pellet was extracted by brief sonication in H1E buffer
with 0.1 M NaCl and 1% Triton X-100, pelleted at 50,000 g, and resus-
pended in H1E buffer. However, data qualitatively similar to those pre-
sented in Results were obtained with the crude pellet. Protein content was
assayed with bicinchoninic acid reagents (Pierce Chemical Co., Rockford,
IL) using BSA as a standard. Purified Engelbreth-Holm-Swarm (EHS)
laminin-1 was obtained from Gibco BRL (Gaithersburg, MD).
Samples were solubilized by boiling in SDS gel loading buffer with or
without DTT. The proteins were then separated by SDS-PAGE and
transferred to nitrocellulose using standard methods. Fusion proteins, re-
duced native laminins, and nonreduced native laminins were separated on
12%, 7%, and 3.5% polyacrylamide gels, respectively. After blotting, fil-
ters were blocked with nonfat dry milk/0.3% Tween-20 in PBS, and then
incubated with antibodies overnight. For detecting the fusion proteins, an-
tisera were preadsorbed to an unrelated fusion protein containing the
common pET 23 leader and His tag sequences. Bound antibodies were
detected with either HRP-conjugated second antibody (for rabbit) or bio-
tinylated second antibody with HRP-conjugated Z-avidin (Zymed Labo-
ratories, South San Francisco, CA) (for guinea pig), and Renaissance
chemiluminescent substrate (DuPont/New England Nuclear, Boston, MA).
For immunoprecipitations, laminins were first partially purified from
adult rat lung by the protocol of Lindblom et al. (1994), modified as fol-
lows: crude membranes were prepared as described above, and then ex-
tracted repeatedly over 12 h with 50 mM Tris, pH 7.5, 0.15 M NaCl, 10
mM EDTA, and 10 mM EGTA (TBS/EDTA). The pooled extracts were
diluted to 90 mM NaCl, adjusted to pH 8.3, and loaded onto a DEAE–
Sepharose CL-4B column (Pharmacia, Uppsala, Sweden). The column was
eluted with 1.0 M NaCl, and fractions containing laminin b2 (detected
by immunoblotting) were pooled and brought to 50% saturation with am-
monium sulfate. Precipitated material was resuspended in TBS/EDTA,
brought to 10% glycerol, 0.6 M KCl, and 0.05% Tween-20, and then frac-
tionated on a Sepharose CL-4B column. Fractions containing laminin b2
were pooled and passed through CM–Sepharose CL-6B; the flow-through
was resubjected to DEAE–Sepharose chromatography. Protein eluted
with 0.5 M NaCl was stored at 2708C with 0.1 mM PMSF. Protein was
measured by Bradford assay (Bio Rad Laboratories, Hercules, CA). SDS-
PAGE of this fraction under reducing conditions displayed a heteroge-
neous population of proteins .180 kD, along with the laminin-binding
protein entactin (150 kD) as a major constituent.
Laminins were immunoprecipitated essentially by the method of Green
et al. (1992), modified as follows: laminin samples were incubated with anti-
b1 mAbs (a mixture of C21 and C22) or anti-b2 antibodies (a mixture of D7,
D19, and D27) in 50 mM Tris, pH 8.0, 100 mM NaCl, 2 mM EDTA, 1%
NP-40, and 0.05% sodium deoxycholate (IP buffer). Immune complexes
were isolated using protein A–Sepharose 4B (Pharmacia) that was pre-
blocked with 4 mg/ml IgG-free BSA (Sigma Chemical Co.) and washed in
IP buffer. Rabbit anti–mouse IgG (Fc) antibodies (Jackson ImmunoRe-
search Laboratories) were included to bridge mAbs to protein A. Precipi-
tated laminins were dissolved by boiling in SDS-PAGE sample buffer,
separated by SDS-PAGE, and then detected by Western blotting as above.
Interspecific Mouse Backcross Mapping
Interspecific backcross progeny were generated by mating (C57BL/6J 3
Mus spretus) F1 females and C57BL/6J males as described (Copeland and
Jenkins, 1991). DNA isolation, restriction enzyme digestion, agarose gel
electrophoresis, and Southern blot transfer and hybridization were per-
formed essentially as described (Jenkins et al., 1982). All blots were pre-
pared with Zetabind nylon membrane (Cuno, Inc., Meriden, CT). Probes,
which were specific for each locus, were labeled with [32P]dCTP using a
random primed labeling kit (Amersham Corp., Arlington Heights, IL) or
a nick translation labeling kit (Boehringer Mannheim Biochemicals); wash-
ing was done to a final stringency of 0.8–1.0 3 SSC and 0.1% SDS at 658C.
The probe and restriction fragment length polymorphisms (RFLPs) for
Lama1 have been described previously (Okazaki et al., 1993). The Lama2
probe, a z360-bp fragment of mouse cDNA from domain G, detected
fragments of 10.5 kb in C57BL/6J (B) DNA and 5.4 and 4.2 kb in M. spre-
tus (S) DNA after digestion with PstI. The Lama3 probe, a z500-bp frag-
ment of mouse cDNA from domains I/II, detected EcoRV fragments of
10.5 kb (B) and z23.0 kb (S). A second probe, a genomic clone containing
a portion of domain VI of laminin a3B, gave results identical to those
obtained with the domain I/II probe. The Lama4 probe, a z800-bp frag-
ment of mouse cDNA from domain G, detected BglII fragments of 4.4
and 1.7 kb (B) and 6.0 kb (S). The Lama5 probe, a z7.5-kb fragment of
mouse genomic DNA from domains V and IVb, detected BamHI frag-
ments of 4.2, 3.7, and 3.3 kb (B) and 4.2, 3.3, 2.3, and 1.8 kb (S). The pres-
ence or absence of M. spretus–specific fragments was followed in back-
cross mice. A total of 205 N2 mice were used to map each Lama locus.
Descriptions of most of the probes and RFLPs for the loci used to posi-
tion the Lama loci in the interspecific backcross have been reported.
These include: Gnas, chromosome 2 (Wilkie et al., 1992); Myb, Fyn, and
Ros1, chromosome 10 (Justice et al., 1990); Fert and Tik, chromosome 17
(Fishel et al., 1993; Okazaki et al., 1993); and Tpl2, Cdh2, and Ttr, chromo-
some 18 (Justice et al., 1992, 1994). One locus has not been reported previ-
ously for this interspecific backcross: the Mc3r probe, a 2.0-kb BamHI/
XhoI fragment of mouse cDNA, was kindly provided by Roger Cone
(Vollum Institute, Portland, OR) and detected SphI fragments of 3.5 kb
(B) and 5.9 kb (S). Recombination distances were calculated as described
(Green, 1981) using the computer program SPRETUS MADNESS. Gene
order was determined by minimizing the number of recombination events
required to explain the allele distribution patterns.
Results and Discussion
The Laminin a Chain Family: Identification of
Full-Length a3
The a subfamily of laminin chains currently contains five
members. Fig. 1 shows the domain structure of these chains
based on the nomenclature of Sasaki et al. (1988). All a
chains contain a carboxyl-terminal globular G domain and
a-helical domains I and II. The previously described full-
length a1 and a2 chains contain six additional domains
(IIIa–VI) that alternate between cysteine-rich stretches
containing EGF-like repeats (IIIa, IIIb, and V) and globu-
lar regions (IVa, IVb, and VI) (Engvall and Wewer, 1996).
The newest member of the family, a5, is also a full-length
chain, but it is larger than a1 or a2, owing to the greater
number of EGF-like repeats in domain V and a larger do-
main IVb (Miner et al., 1995). In contrast, laminins a3A and
a4 are severely truncated chains that contain only a single
cysteine-rich domain (IIIa) downstream of a short amino-
terminal domain (Ryan et al., 1994; Galliano et al., 1995;
Iivanainen et al., 1995; Richards et al., 1996). Of the verte-
brate a chains, a5 may be most like the ancestral a chain,The Journal of Cell Biology, Volume 137, 1997 688
because of its similarity in both domain structure and se-
quence to the only known invertebrate a chain, Drosoph-
ila A (Miner et al., 1995).
The only laminin gene so far shown to encode more
than a single polypeptide is the laminin a3 gene. The two
known products, a3A and a3B, differ at their amino ter-
mini, resulting from alternative splicing and/or alternative
promoter usage. The shorter a3A chain was the first to be
identified by both immunological methods (Rousselle et al.,
1991) and by cDNA cloning (Aberdam et al., 1994b). Sub-
sequently, however, multiple a3 cDNAs were identified in
human (Ryan et al., 1994) and mouse (Galliano et al., 1995),
suggesting the existence of a second, longer isoform called
a3B. Sequence analysis (Galliano et al., 1995) indicated
that a3B contains two cysteine-rich (IIIa and IIIb) and
two globular (IVa and IV99) domains in addition to the G
and I/II domains, but no domains V or VI. This would
make it the sole “mid-sized” a chain. However, we have
obtained mouse cDNAs (see Materials and Methods) that
extend the previously reported sequence 59 by z2.2 kb
(Fig. 2). This novel sequence encodes the NH2-terminal
portion of domain IVb, a complete domain V, and what is
likely all but a few amino acids of a domain VI. These do-
mains are most similar in sequence and predicted tertiary
structure to the analogous domains of laminin a5. For ex-
ample, the amino acid sequence of domain VI is 74% iden-
tical to that of a5, but only 54 and 51% identical to those
of a1 and a2, respectively. A probe from the 59 end of this
sequence recognized z10-kb bands on Northern blots of
mouse RNA from adult brain, lung, and kidney (data not
shown). The proposed a3B structure is shown in Fig. 1, in-
dicating its unique NH2 terminus and the COOH terminus
it shares with a3A.
There is a discrepancy between our sequence and that of
Galliano et al. (1995): a single base near the 59 end of their
reported sequence is absent from our cDNAs (see last line
of Fig. 2). As a result of this insertion, the methionine resi-
due that Galliano et al. (1995) suggested to initiate transla-
tion of a3B and the following amino acid are encoded in a
different reading frame than is the extended sequence re-
ported here (Fig. 2). Possible explanations for this discrep-
ancy include a polymorphism between mouse strains, al-
ternative splicing of exons that differ by only one base,
RNA editing, sequencing error, or cDNA cloning artifact.
We cannot exclude any of these possibilities, although we
consider the first three unlikely and note that our se-
quence, derived from multiple cDNAs, generates a single
uninterrupted open reading frame (z9.8 kb) extending
through the region of discrepancy. Therefore, we favor the
interpretation that there is no mid-sized form of laminin
a3, but only the severely truncated a3A and the full-length
a3B form reported here. Full-length a3B would thus con-
tain z3,300 amino acids and have a molecular mass of
z360 kD. Thus, the a subfamily of laminin chains cur-
rently consists of four long (a1, a2, a3B, and a5) and two
short (a3A and a4) proteins.
Differential Expression of Laminin a Chain Genes in 
Embryos and Adults
As a first step in assessing the distribution of the laminin a
chains, we performed RNase protection analyses on RNA
isolated from a set of eight adult tissues plus a late-term
Figure 1. The laminin a chain subfamily. Numbering of domains
is based on accepted nomenclature (Sasaki et al., 1988; Engvall
and Wewer, 1996). Numbers of laminin-type cysteine-rich (EGF-
like) repeats, rounded to the nearest integer, are indicated within
each domain IIIa, IIIb, or V. Note that laminins a3A and a3B
share domains G, I/II, and IIIa but have distinct NH2 termini.
Figure 2. Nucleotide and deduced amino acid sequences of the
laminin a3B chain, 59 and NH2-terminal to those reported by
Galliano et al. (1995). Overlapping nucleotides are in lowercase.
The Galliano sequence contains a single deoxyguanosine (paren-
theses) not found in our sequence, which shifts the reading frame
and leads to an encoded methionine (bottom line, italics). Domains
are marked as in Fig. 1. This was hypothesized to be the initiator
for translation. An adhesive tripeptide sequence, LRE (Hunter
et al., 1989a), is indicated by bullets; another LRE is located in
the G domain (Galliano et al., 1995). These sequence data are
available from GenBank under accession number U88353.Miner et al. The Laminin a Chains 689
(E17.5) placenta (Fig. 3 A). Laminin a1 was readily detect-
able only in placenta, but long autoradiographic exposures
revealed low levels in kidney. Laminin a2 RNA was present
at levels above background (yeast RNA lane) in heart,
kidney, lung, muscle, and skin. Laminin a3A/B was ex-
pressed primarily in lung, skin, and intestine, although
very low levels of this RNA were also detectable in kid-
ney. In contrast, laminin a4 RNA was present in all tissues
at low (liver) to moderate (lung) levels. Laminin a5 tran-
scripts were also easily detectable in all tissues, although
levels were very low in liver. Thus, each laminin a chain is
expressed in a distinct pattern. Interestingly, the two most
recently discovered laminins, a4 and a5, are the most
widely expressed. The a2 and a3 chains show more re-
stricted patterns of expression. In general, a2 levels were
highest in tissues with large mesodermally derived compo-
nents (skeletal and cardiac muscle), whereas a3 levels
were highest in organs that are rich in epithelia (skin, in-
testine, and lung). The notion that a2 and a3 are predomi-
nantly mesodermal and epithelial products, respectively,
has been proposed (Vuolteenaho et al., 1994; Aberdam
et al., 1994a). Finally, expression of laminin a1, the ini-
tially described a chain, was the most severely restricted of
the five.
We next tested RNAs prepared from the same tissues
but at a late fetal (E17.5) stage. In general, patterns of ex-
pression seen in the fetus were similar to those seen in
adults, although levels of expression were generally higher
in the fetus (Fig. 3 B). Laminin a1 was again the least
widely expressed a chain, although its RNA was readily
detected in fetal kidney as well as in placenta. Likewise,
laminins a2–5 were expressed at moderate to high levels in
a variety of tissues, consistent with patterns seen in adults.
Thus, the distinct patterns of laminin a chain expression
found in adult tissues are, for the most part, established
before birth.
To map a chain expression in younger embryos (E15.5),
we used in situ hybridization. Laminin a1 was detected in
the kidney and in the meninges of the central nervous sys-
tem (Fig. 4 a). Laminin a2 was observed primarily in the
developing skeletal musculature, in dorsal root ganglia,
and in kidney (Fig. 4 b). Laminin a3A/B was strongly ex-
pressed in skin, lung, olfactory epithelium, and the superfi-
cial layers of the tongue and palate (Fig. 4 c). Laminin a4
was expressed strongly in mesenchymal tissues of the head,
in dorsal root ganglia, and in intestine, and was observed
diffusely in skeletal and cardiac muscle (Fig. 4 d). Finally,
laminin a5 was expressed in a pattern similar to a3, with
additional sites of expression in salivary gland, in intestine,
and in the most superficial cells of the liver (Fig. 4 e).
When compared with the RNase protection results from
E17.5 (Fig. 3 B), it is apparent that the main sites of ex-
pression are already established by E15.5: a2 and a4 in
muscle, a3 and a5 in skin, and a3–5 in lung. There are,
however, a few differences. For example, a2 is barely de-
tectable in heart at E15.5 but is expressed strongly at
E17.5; the presence of a4 in heart at E15.5 suggests that
there may be a developmental transition in a chain expres-
sion in the heart in which a4 is joined by a2. In addition, a
particularly interesting pattern of a3–a5 chain expression
was observed in the lung, as shown at higher power in Fig.
4, f–h. a3 and a5 were confined to the epithelial lung buds
at this stage, while a4 was expressed only in the surround-
ing mesenchyme. This complementary pattern of expres-
sion suggests that these chains may play distinct roles in
lung development: a3 and a5 in branching morphogenesis,
and a4 in the organization of the mesenchyme.
Identification of Laminin a4 and a5 Proteins
The a1–3 chains were first identified by biochemical and
immunochemical methods (Timpl et al., 1979; Leivo and
Engvall, 1988; Rousselle et al., 1991; Carter et al., 1991; Ver-
rando et al., 1992). In contrast, a4 and a5 were identified
as cDNAs by molecular cloning (Richards et al., 1994; Ii-
vanainen et al., 1995; Miner et al., 1995). Sequence analy-
sis implies that the a4 and a5 cDNAs encode laminin-like
proteins, but it is crucial to demonstrate this directly. To
this end, we used a4 and a5 cDNAs to produce recombi-
nant proteins in bacteria, and then used the proteins to
generate antisera in rabbits. Each antiserum specifically
recognized its immunogen on Western blots (Fig. 5 A), and
immunoreactivity was removed by incubation with the
Figure 3. Ribonuclease protection analysis of laminin a chain ex-
pression in (A) adult and (B) E17.5 mouse tissues. A probe for
elongation factor 1a was used to control for the amount of input
RNA in both embryos (B) and adults (not shown). Each a chain
is expressed in a distinct pattern in the adult and, in general, these
patterns are established by birth. The a5 chain is the most highly
expressed, and a1 is the most restricted. B, brain; I, intestine; H,
heart; K, kidney; Li, liver; Lu, lung; M, skeletal muscle; S, skin; P,
placenta; Y, yeast RNA. The sample of E17.5 placental RNA was
included in the panel of adult RNAs to allow comparison be-
tween experiments. nd, not done.The Journal of Cell Biology, Volume 137, 1997 690
corresponding fusion protein. Since a3B and a5 sequences
are closely related (see above), we also tested anti-a5 on a
recombinant fragment from the corresponding domains of
a3B. No cross-reaction was detected (data not shown).
To detect laminin a4 and a5 proteins, we prepared ex-
tracts of adult lung and kidney; lung was chosen because it
expresses both chains at high levels (Fig. 3 A), and kidney
was chosen because it was the focus of immunohistochem-
ical studies detailed below. Tissue BL proteins and puri-
fied laminin-1 (a1/b1/g1) were reduced, fractionated by
Figure 4. In situ hybridization of laminin a chain probes to E15.5 embryo parasagittal sections. (a) a1, (b) a2, (c) a3, (d) a4, and (e) a5.
a1 shows restricted expression in kidney and meninges (arrowheads); a2 and a4 show widespread expression in mesenchymal cells and
derivatives as well as in dorsal root ganglia (arrowheads); and a3 and a5 transcripts localize primarily to epithelia. (f–h) High power
views of (f) a3, (g) a4, and (h) a5 expression in lung. a3 and a5 are concentrated in the epithelial lung buds, and a4 to the mesenchyme.
H, heart; K, kidney; L, lung; SG, salivary gland; T, tongue (muscle). Bars: (d) 1 mm; (h) 50 mm.Miner et al. The Laminin a Chains 691
gel electrophoresis, and transferred to nitrocellulose fil-
ters, which were then probed with antisera to laminins a4
or a5 or with an antiserum to laminin-1. Results are shown
in Fig. 5 B. Anti-a4 recognized an z180-kD protein in
both lung and kidney (Fig. 5 B, lanes 3 and 8). Anti-a5 rec-
ognized large proteins of z380 and z350 kD, as well as a
smaller protein of z210 kD, in both tissues (Fig. 5 B, lanes
4 and 9). Additional specific anti-a5–reactive bands of
high Mr (z450 kD) were observed with longer exposure
times in several experiments (Fig. 5 B, lane 5). Neither
anti-a4 nor anti-a5 reacted with the z400-kD a1 chain of
laminin-1 (Fig. 5 B, lanes 12 and 13), although this chain
was readily detected by a polyclonal antiserum to laminin-1
(lane 10). Nonimmune rabbit serum was not reactive with
any of the laminin chains (Fig. 5 B, lanes 2, 7, and 11).
Thus, the laminin a4 and a5 chains are present in adult
lung and kidney, and this is consistent with results of
RNase protection assays (Fig. 3 A).
The Mr of the anti-a4–reactive protein, z180 kD, is con-
sistent with the size predicted from the open reading frame
of the cDNA (190 kD; Iivanainen et al., 1995; Richards et al.,
1996). Likewise, the z450-kD a5 chain is of the expected
size for this presumably glycosylated protein. The observa-
tion that smaller a5-immunoreactive bands (380, 350, and
210 kD) are more abundant than the 450-kD species indi-
cates that a5 is subject to posttranslational cleavage. Mul-
tiple protease inhibitors were used in preparing tissue, and
the relative abundance of the bands in the extracts re-
mained constant for several weeks at 48C. We therefore
suspect that this cleavage occurred in situ, as has been re-
ported for laminins a2 and a3 (Ehrig et al., 1990; Marin-
kovich et al., 1992a), rather than during isolation.
Cellular Distribution of Laminin a Chains
in Adult Tissues
The laminin a1–3 chains have been shown to be associated
with BLs in a variety of tissues, as have the b and g chains.
Here we asked whether a4 and a5 are components of BLs,
and whether their expression overlaps those of the a1–3
chains. In addition, we wanted to know whether all BLs
contained at least one a chain, as the finding of an appar-
ently a-free BL might suggest the existence of additional a
chains. We began by using our a4 and a5 antisera, along
with previously characterized antibodies to a1–3 (see Ma-
terials and Methods), to investigate the expression pat-
terns of the laminin a chains in kidney, a tissue that con-
tains numerous heterogeneous yet well-characterized BLs
(Abrahamson et al., 1989; Sanes et al., 1990; Abrahamson
and Leardkamolkarn, 1991; Abrahamson and St. John,
1993; Miner and Sanes, 1994; Virtanen et al., 1995).
Laminin a1 was readily detected in the BLs of a subset
of renal tubules (primarily proximal), as shown previously
(Horikoshi et al., 1988; Sorokin et al., 1992). The a1 chain
was absent from glomerular BL but was present in the
glomerular mesangium, an amorphous matrix that is one
of the few sites in which laminins are present outside of a
formed BL (Fig. 6 a). No a1 was detectable in the BLs of
arteries, veins, or capillaries. In the peripheral portion of
the kidney, laminin a2 was largely restricted to the me-
sangium, in agreement with previous studies of human
kidney (Fig. 6 b; Sanes et al., 1990; Virtanen et al., 1995).
At deeper levels, however, some tubules were weakly a2
positive, particularly in the transitional zone between the
cortex and medulla (the corticomedullary junction; Fig. 6 b,
inset). Laminin a3 was absent from glomeruli, tubules, and
vasculature of the renal cortex (data not shown), but it was
present in the epithelial BL that lines the papilla (Fig. 6 c).
Laminin a4 was absent from all renal, epithelial, and arte-
rial BLs (Fig. 6 d) but was found in many capillaries of the
medulla (not shown). Finally, laminin a5 was detected in
virtually all BLs, including those of glomeruli, arteries, and
all tubules (Fig. 6 e). Thus, all five of the known a chains
Figure 5. Identification of laminin a4 and a5 proteins in lung and
kidney. (A) Characterization of antisera. The a4 and a5 fusion
proteins used to immunize rabbits were fractionated by SDS-
PAGE on 12% gels and transferred to blots. Strips were probed
either with no primary antibody (lanes 1 and 4), with the anti-a4
antiserum (lanes 2 and 5), or with the anti-a5 antiserum (lanes 3
and 6). Each antiserum specifically recognized its cognate immu-
nogen. (B) Solubilized and reduced crude membranes from adult
rat lung and kidney and purified laminin-1 were fractionated on
7% gels and transferred to blots. Strips were probed either with
anti–laminin-1 (lanes 1, 6, and 10), nonimmune (lanes 2, 7, and
11), antilaminin a4 (lanes 3, 8, and 12), or anti-laminin a5 (lanes
4, 5, 9, and 13). The anti-a4 serum recognized a protein of z180
kD in lung and kidney. The a5 antiserum recognized several
bands in lung and kidney (lanes 4 and 9), the largest of which,
z450 kD, was observed only after long exposures (lane 5, arrow-
heads). Neither serum recognized laminin a1 (lanes 12 and 13).
n.i., nonimmune serum; x, nonspecific bands seen in all lung lanes
with long exposures.The Journal of Cell Biology, Volume 137, 1997 692
Figure 6. Immunohistochemical localization of laminin a chains in adult mouse kidney (a–e), heart (f–j), and lung (k–o). All five a
chains were present in adult BLs, but each chain was distributed in a distinct pattern. a1 was found only in kidney mesangium and in a
subset of tubular BLs (primarily proximal) (a). a2 was present in mesangium (b), in a subset of corticomedullary tubular BLs (b, inset),
and in cardiomyocyte BLs (g). a3 was detected in kidney papillary BL (c) and in lung alveolar BL (m). a4 was absent from renal cortex
(d) but found in capillaries of both the renal medulla (not shown) and heart (i), and in alveolar BLs in lung (n). a5 showed the most
widespread expression: in all kidney BLs—glomerular, tubular, and arterial (e); in heart blood vessels and in some cardiomyocyte BLs
(j); and in lung alveolar BL (o). G, glomerulus; M, mesangium; bv, blood vessel. Bar, 50 mm.Miner et al. The Laminin a Chains 693
are present in adult kidney, but each is expressed in a
unique pattern.
To extend these studies, we examined two other BL-rich
tissues, heart and lung. As in kidney, the laminin a chains
were primarily restricted to BLs, and each chain was ex-
pressed in a distinct pattern. In the heart, laminins a1 and
a3 were undetectable (Fig. 6, f and h). Laminin a2 was
abundant in the myocyte BLs (Fig. 6 g), as reported previ-
ously (Leivo and Engvall, 1988; Paulsson et al., 1991), while
laminin a4, as in the kidney, was restricted to capillaries
(Fig. 6 i). Laminin a5 was present in arterioles and capil-
laries and was also found at low levels in many myocyte
BLs (Fig. 6 j). In lung, laminin a3 was present in alveolar
BL (Fig. 6 m), consistent with a recent report by Virtanen
et al. (1996). The a5 chain was colocalized with a3 in most
alveolar BLs (Fig. 6 o), while laminin a4 was detected in a
large subset of these BLs (Fig. 6 n). The identity of the a4-
positive BLs remains to be determined. Interestingly, how-
ever, in developing lung, protein localization mirrors the
RNA localization documented above: a3 and a5 are con-
centrated in the epithelial lung buds, with a4 in the mesen-
chyme (data not shown; Miner, J.H., manuscript in prepa-
ration). Laminins a1 and a2 were not detectable in lung
(Fig. 6, k and l).
Several conclusions can be drawn from these results.
First, all laminin a chains are confined to the extracellular
matrix and, with the exception of the glomerular me-
sangium, to BLs. Cytoplasmic deposits of laminins were
not detected, nor were any laminin a chains present in the
interstitial collagen– and fibronectin-rich matrix between
tubules (in kidney) or myocytes (in heart). Second, each a
chain is expressed in a unique pattern. Third, each BL con-
tains at least one a chain. Fourth, BLs can contain either a
single a chain (e.g., a5 in glomerular BL) or multiple a
chains (e.g., a1 and a5 in proximal tubular BL or a3, a4,
and a5 in some alveolar BLs). Fifth, even a single BL can
vary in laminin composition along its length (e.g., a1 and
a5 in proximal portions of tubular BL, a5 in distal por-
tions, and a2 and a5 at the corticomedullary junction).
Sixth, as surmised from studies at the RNA level (see above),
a1 is most restricted in its expression, and a5 is the most
broadly distributed in adult BLs. Together, these results
support the idea that the functional diversity of BLs is
achieved in part by laminin a chain diversity.
Finally, it is interesting to compare the distribution of
the individual a chains to that previously documented for
a1. Many studies, including some from our laboratory,
have used the mAb 4C7 (Engvall et al., 1986) to assess the
distribution of a1 (Engvall et al., 1990; Sanes et al., 1990;
Virtanen et al., 1995, 1996; Sewry et al., 1995; Durham and
Snyder, 1995). This antibody was shown to recognize a
laminin  a chain distinct from a2 at a time when only two a
chains had been described (Engvall et al., 1990), but since
this antibody does not recognize mouse protein, it could
not be tested on bona fide laminin a1 as originally isolated
and cloned from the EHS tumor. 4C7-immunoreactive
material is more broadly distributed than is a1-immunore-
active material, as recognized by mAbs that bind to mouse
laminin a1 (Sorokin et al., 1992) and were used here. In-
terestingly, the array of BLs recognized by 4C7 most
closely resembles that stained by anti-a5 in heart, lung,
and kidney (Fig. 6), as well as in skeletal muscle (Patton,
B.L., J.H. Miner, and J.R. Sanes, unpublished results). Un-
fortunately, direct comparisons are not feasible because
4C7 does not recognize mouse or rat antigen, and our anti-
a5 antiserum does not recognize rabbit or human antigen.
However, we speculate that 4C7 may recognize the lami-
nin a5 chain, either instead of or in addition to a1.
Developmental Transitions in Laminin
a Chain Expression
We next used our panel of antisera to ask when develop-
ing BLs acquire their complement of laminin a chains.
Based on the studies of adult organs detailed above, and
on the fact that laminins have been implicated as impor-
tant in renal development and function (Klein et al., 1988;
Noakes et al., 1995), we focused on kidney for this analy-
sis. In fact, we found a complex and dynamic pattern of
laminin a chain expression in the BLs of the developing
nephron. To document these results, it is first necessary to
summarize the main stages of nephrogenesis (Fig. 7).
Nephrogenesis begins when the epithelial ureteric bud
grows out of the mesonephric duct, invades loose meta-
nephric mesenchyme, and induces it to condense into a
sphere (Fig. 7 A). The condensed mesenchyme then epi-
thelializes, forming a vesicle, and secretes a BL around its
periphery (Fig. 7 B). One side of the vesicle and then the
other invaginates to form, successively, a comma-shaped
and an S-shaped figure (Fig. 7, C and D); during this pro-
cess, a blood vessel invades the primary invagination.
Next, the distal portion of the S-shaped body fuses with
the ureteric bud to form the tubule, and the invading ves-
sel branches within the widening invagination to form the
rudimentary capillary loops of the glomerulus (Fig. 7 E).
Further ramification of the capillary loops and their enclo-
sure by glomerular constriction lead successively to the
immature and mature glomeruli (Fig. 7, F and G). Multiple
waves of induction of cortical mesenchyme by the branching
and lengthening ureteric bud make nephrogenesis a graded
process that continues from E11 until postnatally, with
newly forming nephrons just beneath the cortical surface
and more mature stages at increasingly deep levels (Abra-
hamson, 1991; Sorokin and Ekblom, 1992; Davies, 1993).
To search for potential developmental transitions in
laminin a chain expression, we stained sections of E15.5
and neonatal mouse kidney with antibodies to laminins
a1–5. Results are summarized in Fig. 7 and examples are
shown in Fig. 8. Before vesicle formation, the only BL
near the cortical surface was that of the ureteric bud. This
BL was rich in laminin a5 (Fig. 8 a) throughout its length
and also contained a1 (Fig. 8 g) in the cortical portions.
The first-formed BL of the nephron, that of the vesicle,
contained laminins a1 (not shown) and a4 (Fig. 8 b). Lami-
nin a1 was detected in the BL of some but not all vesicles,
suggesting that it appears after a4 near the end of the vesi-
cle stage. In the comma, a1 and a4 remained (Fig. 8, c and
e) and were joined by a5 (Fig. 8 a). At this stage, signifi-
cant heterogeneity became evident within the single BL
that surrounded each comma: laminin a4 was present at
higher levels in the tuft than in the periphery (Fig. 8 c),
whereas laminin a5 was clearly present in the periphery
but was virtually absent from the tuft (Fig. 8 a). Thus, the
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becomes molecularly distinct from continuous but nonglom-
erular stretches of BL at an early stage of nephrogenesis.
At the S-shaped stage, distinct portions of the nephron
that will give rise to the glomerular filtration apparatus,
Bowman’s capsule, and the tubule can be distinguished.
Interestingly, BLs in each of these regions bore a different
complement of laminin a chains. The progenitor of the
glomerular BL was rich in a4 and a5 and contained low
levels of a1; the progenitor of Bowman’s capsule BL was
rich in all three chains; and the progenitor of the tubular
BL contained abundant a1, low levels of a5, and no de-
tectable a4 (Fig. 8, d and f). In addition, the invading ves-
sel, destined to generate the capillary loops of the glomer-
ulus, was coated by a BL with yet a fourth composition:
rich in a4 but with no detectable a1 or a5.
As summarized in Fig. 7, E–G, and documented in Fig.
8,  d,  g, and h, each stretch of BL underwent further
changes in laminin a chain composition as the nephron
matured. (1) In the BL of Bowman’s capsule, a4 declined
in level by the capillary loop stage and disappeared from
the capsule in the immature glomerulus. Levels of a1 de-
clined later, leaving the mature capsular BL rich in a5,
poor in a1, and without detectable a4. (2) Tubular BL be-
came richer in a5 as development proceeded. Different
segments of the tubule either maintained or lost a1, or ac-
quired a2, as described above (Fig. 6, a–e). (3) Arteriolar
BL lost a4 and acquired a5 at a late stage of development.
(4) The glomerular BL first lost a4 and then lost a1, leav-
ing a5 as the only detectable laminin a chain in the adult.
(5) Finally, the mesangial matrix was first detectable at the
Figure 7. Schematic sum-
mary of kidney development,
and expression patterns of
the laminin a chains in vari-
ous nephron segment BLs.
The laminin a and b chains
expressed in the developing
glomerular BL (GBM) and
its progenitors are boxed.
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Figure 8. Immunohistochemical analysis of laminins a1, a4, a5, and g1 in developing kidney shows the dynamic pattern of a chain accu-
mulation depicted schematically in Fig. 7. All sections are from P1 mouse kidney except c, which is from E15.5. b9, c, d9, f9, g, and h9 are dou-
ble exposures of doubly labeled sections; antibodies listed first and second are shown in green and red, respectively, and regions of over-
lap are indicated by yellow and light orange. Single exposure companions are shown in b (for b9), d (for d9), f (for f9), and h (for h9). U,
ureteric bud; V, vesicle; C, comma-shaped structure; S, S-shaped structure; CL, capillary loop; mG, maturing glomerulus; bv, blood ves-
sel. (Arrows) Progenitors of glomerular BL. Bar, 50 mm.The Journal of Cell Biology, Volume 137, 1997 696
capillary loop stage, where it was a4 positive. Later, a4
disappeared from this matrix, and a1 and a2 accumulated.
It is interesting to compare the laminin a chain transi-
tions in glomerular BL to those previously documented
for the laminin b and collagen IV a chains (Abrahamson
and St. John, 1993; Miner and Sanes, 1994; Noakes et al.,
1995; Virtanen et al., 1995). Laminin b1 and collagen
a1,2(IV) chains are present in the primitive comma and
S-shaped figure BLs. At the capillary loop stage, they are
joined by laminin b2 and collagen a3-5(IV) in the devel-
oping glomerular BL. At the immature glomerulus stage,
laminin b1 and collagen a1,2(IV) levels begin to decline,
leaving only laminin b2 and collagen a3-5(IV) in the ma-
ture glomerular BL. The later appearance of a5 and b2
raises the possibility that these two events are linked.
However, the initial accumulation of laminin a5 occurs at
the S-shaped stage, while laminin b2 and collagen a3-
5(IV) do not appear until the capillary loop stage (Fig. 7,
D and E). Likewise, the roughly parallel disappearance of
laminins a1, a4, and b1 raises the possibility that this de-
velopmental step reflects loss of a1b1- or a4b1-containing
trimers. However, laminin b1 was detectable in maturing
glomerular BLs that lacked laminins a1 and a4 (data not
shown), suggesting that elimination of these molecules is
not obligatorily linked. Surprisingly, therefore, the devel-
opmental transitions in laminin a and b chains appear to
be regulated independently. If all laminin chains occur in
a/b/g trimers (see below), these results suggest that a1b1-,
a1b2-, a4b1-, a4b2-, a5b1-, and a5b2-containing trimers
are potentially present, at least transiently, in developing
glomerular BL.
To determine whether the isoform transitions detected
at the protein level reflected regulation of gene expres-
sion, we performed in situ hybridizations on P1 kidney sec-
tions using probes for the a1–5 chains. As noted above,
nephrons at all stages of development are present in a cor-
ticomedullary gradient in neonates, with the most primi-
tive just beneath the cortical surface and the most mature
at deeper levels. Laminin a4 transcripts were clustered at
the cortex, as expected from its early appearance in vesicu-
lar BL (Fig. 9 d). Laminin a1 transcripts were detected in
cortical and subcortical clusters, consistent with the ex-
pression of this chain in late vesicle, comma, and S-shaped
stages (Fig. 9 a). Segments of tubules were also a1 posi-
tive, and lower level expression (above background) was
found throughout the kidney. Low levels of laminin a5 RNA
were present in the superficial layer of the cortex, consis-
tent with the later appearance of this chain in the develop-
ing nephron. Occasional clusters that were observed are
likely to be the tips of the ureteric buds that have BLs rich
in a5 (Fig. 9 e). Deep in the medulla, laminin a5 RNA was
abundant in the collecting ducts, which are derived from
the a5-positive ureteric bud. a5 labeling was not abundant
in all structures that contained the protein (e.g., capillary
loop stage glomeruli), suggesting that, in some cases, a5
RNA is unstable or simply present at low levels but trans-
lated efficiently. Laminin a2 RNA was concentrated in the
deep cortical and medullary portions of the kidney (Fig. 9 b),
consistent with its localization in a subset of tubules (Fig. 6 b).
Laminin a3 RNA was not detectable within the renal cortex
but was found at P15 in the papilla (data not shown), con-
sistent with its protein localization in adult kidney (Fig. 6 c).
Identification of Heterotrimers Containing the Laminin 
a4 or a5 Chain
Current understanding of the structure and function of
BLs is based on the assumption that all laminins are het-
erotrimers of a, b, and g subunits, covalently joined by di-
sulfide bonds (Burgeson et al., 1994). Such trimeric struc-
tures have been demonstrated for the a1–3 chains, which
form laminins 1–7 (Table I), but not for a4 and a5. We
therefore asked whether the a4 and a5 chains also occur
as components of trimers. To this end, we fractionated
proteins from lung and kidney on SDS gels under nonre-
ducing conditions such that laminins migrate as trimers,
the relative sizes of which depend on the constituent a, b,
and g chains. Nitrocellulose blots were then probed with anti-
bodies to a4 or a5 (Fig. 10 A). Both lung and kidney con-
tained high Mr complexes that reacted with the a4 (Fig. 10
A, lanes 3 and 7) or a5 (lanes 4 and 8) antisera but not
with nonimmune serum (lanes 2 and 6). The a4 complexes
were z500–600 kD, and the a5 complexes were z700–800
kD. These values are consistent with Mrs predicted for lami-
nin trimers. None of the a4- or a5-immunoreactive bands
(<450 kD) that had been seen after reduction (Fig. 5 B)
were detectable under these nonreducing conditions, indi-
cating that all of the monomeric species were associated
with larger, disulfide-bonded complexes. Moreover, the ap-
proximate difference in Mr between the a4- and a5-contain-
ing complexes (z200 kD) is consistent with the difference
in Mr between the full-length a4 and a5 chains themselves.
An antiserum to laminin-1, which recognizes the a1, b1, and
g1 chains, blotted material at the Mrs of all a4- and a5-
containing complexes (Fig. 10 A, lanes 1 and 5), whereas
anti-a4 and anti-a5 did not recognize laminin-1 (lanes 11
and 12). Together, these results suggest that laminins a4
and a5 occur in heterotrimers with b1 and/or g1 chains.
To definitively identify the a4- and a5-containing com-
plexes as laminin heterotrimers, we solubilized and par-
tially purified laminins from lung. Lung was chosen for this
set of experiments because, unlike kidney, it expresses both
a4 and a5 chains at high levels in adulthood (Figs. 3 and 6).
Lung homogenates were extracted with EDTA, EGTA,
NaCl, and Triton X-100, and the extracts were then frac-
tioned by a combination of ion exchange and size exclu-
sion chromatography (see Materials and Methods). The
resulting laminin-rich fraction was then subjected to im-
munoprecipitation with mAbs specific for laminin b1 or
b2. Precipitates were separated on gels under nonreducing
conditions, electroblotted onto nitrocellulose, and probed
with antibodies specific for individual laminin chains (Fig.
10 B). Antibodies to laminin b1 precipitated a series of
complexes of z500–800 kD (Fig. 10 B, lanes 1–5). All the
complexes comigrated with g1 (Fig. 10 B, lane 5), but none
contained b2 (lane 2). Individual complexes reacted with
either anti-a4 (Fig. 10 B, lane 3) or with anti-a5 (lane 4)
but not with both. Complexes containing a4 had Mrs of
z500–600 kD, and those with a5 had Mrs of z700–800 kD,
corresponding to Mrs of the nonreduced a4 and a5 com-
plexes observed by immunoblotting crude lung samples (Fig.
10 A). Controls in which the primary antibody was omitted
did not contain laminins (Fig. 10 B, lanes 14–18). Thus, the
laminin a4 and a5 chains are both associated with b1 in
distinct heterotrimers.Miner et al. The Laminin a Chains 697
Parallel results were obtained from material precipi-
tated by antibodies to laminin b2 (Fig. 10 B, lanes 6–10).
All of the laminin b2-reactive material precipitated by
these antibodies (Fig. 10 B, lane 7) reacted with anti g1
(lane 10) and with either anti-a4 (lane 8) or anti-a5 (lane
9) but not both. Complexes containing a4 had Mrs of
z500–600 kD, and those with a5 had Mrs of z700–800 kD,
corresponding to those detected in crude lung samples
(Fig. 10 A). Electrophoresis of the immunoprecipitates un-
der reducing conditions revealed that the major a4- and
a5-reactive bands detected in crude extracts (Fig. 5 B)
were complexed with b2 (data not shown). Thus, lung also
contains distinct laminin heterotrimers that include
a41b2 and a51b2.
Two observations indicated that the complexes contain-
ing a4b1, a4b2, a5b1, and a5b2 also contained the g1 chain.
First, an mAb to g1 precipitated a4- and a5-containing
complexes (Fig. 10 B, lanes 11–13) that were equivalent in
Mr to those precipitated by anti-b1 or anti-b2. Second, as
noted above, anti-b1 and anti-b2 precipitated g1-containing
complexes that comigrated with all of the a4- and a5-
immunoreactive trimers (Fig. 10 B, lanes 5 and 10). Together,
these results provide strong evidence for the existence of
laminin trimers with chain compositions of a4b1g1, a4b2g1,
Figure 9. In situ hybridization of laminin a chain probes to P1 kidney sections. a1 was observed in primitive structures in the cortex and
in some tubules (a). a2 was absent from the cortical structures but distributed diffusely in the interior (b). a4 was detected primarily in
clusters at the cortex (vesicle and comma stage nephrons) but also diffusely in the medulla (d). a5 was mainly in the collecting ducts, but
there were also grain clusters in the inner cortex and in the medulla (e). a3 was absent (c), and a sense control was negative (f). These
patterns suggest that the developmental transitions demonstrated immunohistochemically in Figs. 7 and 8 reflect, in part, developmental
transitions in a chain gene expression. The cortical surface of the kidney is outlined in white. Insets in a–e show higher power views of
the cortex. Bars: (f) 0.5 mm; (a, inset) 0.1 mm.
Table I. Composition of Laminin Trimers
Trimer Components References
Laminin-1 a1b1g1 Beck et al., 1990
Laminin-2 a2b1g1 Engvall et al., 1990
Laminin-3 alb2g1* Engvall et al., 1990
Laminin-4 a2b2g1 Engvall et al., 1990
Laminin-5 a3b3g2 Rousselle et al., 1991
Laminin-6 a3b1g1 Marinkovich et al., 1992b
Laminin-7 a3b2g1 Champliaud et al., 1996
Laminin-8 a4b1g1 This study
Laminin-9 a4b2g1 This study
Laminin-10 a5b1g1 This study
Laminin-11 a5b2g1 This study
*a1 identified immunochemically with the 4C7 mAb.The Journal of Cell Biology, Volume 137, 1997 698
a5b1g1, and a5b2g1. In accordance with recently adopted
rules of nomenclature (Burgeson et al., 1994), these are
named laminins 8–11, respectively (Table I).
Chromosomal Mapping of Lama Genes
The murine chromosomal locations of Lama1–Lama5
were determined using an interspecific backcross mapping
panel derived from crosses of [(C57BL/6J 3 M. spretus)
F1 X C57BL/6J] mice. Mouse genomic or cDNA fragments
specific for each locus were used as probes in Southern
blot hybridization analysis of C57BL/6J and M. spretus ge-
nomic DNA that was separately digested with several dif-
ferent restriction enzymes to identify informative RFLPs
(see Materials and Methods). The strain distribution pat-
tern of each RFLP in the interspecific backcross was then
determined by following the presence or absence of
RFLPs specific for M. spretus in backcross mice.
Backcross mapping refined previously reported chromo-
somal locations for Lama1–3 and provided the first data
on mouse chromosomal locations of Lama4 and Lama5
(Fig. 11). Lama1 has previously been reported to map to
the distal region of mouse chromosome 17 in this interspe-
cific backcross (Okazaki et al., 1993; Doyle et al., 1996).
Lama2 mapped to the proximal region of mouse chromo-
some 10, 4.5 centiMorgans (cM) distal of Myb and 3.9 cM
proximal of Fyn. This result is in good agreement with pre-
vious studies that map Lama2 3.2 6 1.8 cM distal of Myb
on mouse chromosome 10 (Sunada et al., 1994). We have
also confirmed the recent results of Aberdam et al. (1994b)
and Griffith et al. (1996) by assigning Lama3 to the proxi-
mal region of chromosome 18. In our interspecific cross,
Lama3 mapped 1.6 cM distal of Tpl1 and 1.1 cM proximal
of Cdh2. Lama4 is linked to Lama2 on chromosome 10
and does not recombine with Fyn in 129 animals typed in
common, suggesting that the two loci are within 2.3 cM of
each other (upper 95% confidence limit). Finally, Lama5
mapped to the very distal region of mouse chromosome 2,
2.2 cM distal of Gnas. Thus, the five Lama loci were dis-
tributed on four different mouse autosomes, indicating
that most of the Lama genes have become dispersed
through evolution.
Previous studies have shown that the Lama2 gene en-
codes the dystrophia muscularis (dy) mouse mutation (Su-
nada et al., 1994; Xu et al., 1994), but no targeted or spon-
taneous mouse mutants have been reported for lama1, 3,
4, or 5. Therefore, we compared our maps of mouse chro-
mosomes 2, 10, 17, and 18 with composite mouse maps that
report the map locations of many uncloned mouse mu-
tations (obtained from the Mouse Genome Database, main-
tained at The Jackson Laboratory, Bar Harbor, ME). Mu-
tations in the vicinity of the Lama genes include thin fur
(thf) near the Lama1 locus; ataxia (ax), twirler (Tw), and
balding (bal) near the Lama3 locus; waltzer (v) and kidney
disease (kd) near the Lama4 locus; and ragged (Ra) and
wasted (wst) near the Lama5 locus. For most of these mu-
tations, the reported phenotypes are not suggestive of a
Figure 10. Biochemical identification of laminins-8, -9, -10, and -11.
(A) Detection of laminin complexes containing a4 and a5. Crude
membrane preparations from adult lung and kidney and purified
laminin-1 were solubilized without reducing agent and fraction-
ated by SDS-PAGE on 3.5% polyacrylamide gels. Proteins were
transferred to nitrocellulose and probed with nonimmune (n.i.)
serum (lanes 2, 6, and 10) or with antibodies to laminin-1 (lanes 1,
5, and 9), a4 (lanes 3, 7, and 11), or a5 (lanes 4, 8, and 12). The
size of the laminin-1 trimer (z800 kD) is indicated. Lung contained
at least two complexes containing a4 (lane 3), while kidney con-
tained multiple a5-positive complexes (lane 8). Laminin-1 con-
tained little or no detectable a4 or a5. (B) Identification of lami-
nin trimers from adult lung. Laminins were solubilized, partially
purified, and then immunoprecipitated with antibodies to laminin
b1 (lanes 1–5), b2 (lanes 6–10), g1 (lanes 11–13), or without pri-
mary antibody (lanes 14–18). The precipitates were then fraction-
ated on nonreducing gels and probed without primary antibody
(lanes 1, 6, 11, and 14), or with antibodies to laminins b2 (lanes 2,
7, and 15), a4 (lanes 3, 8, 12, and 16), a5 (lanes 4, 9, 13, and 17),
and g1 (lanes 5, 10, and 18). Four novel laminin trimers were
identified: laminin-8 (a4b1g1), laminin-9 (a4b2g1), laminin-10
(a5b1g1), and laminin-11 (a5b2g1).Miner et al. The Laminin a Chains 699
BL defect. For ragged, however, the phenotype is an in-
triguing one. The mutation Ra shows semidominance, and
the coats of heterozygotes have a thin ragged appearance.
Homozygotes are naked, many die in utero, and there are
internal visceral defects (Carter and Phillips, 1954; Slee,
1957). Another semidominant allele of ragged, Ra , op .
(opossum) (Green and Mann, 1961), is homozygous lethal
before E11, which, because of its expression in many tis-
sues, might be expected for a Lama5 mutant. Also, since
a5 is expressed in the skin, a mutation may affect the func-
tion of hair follicles, which could lead to the ragged coat
appearance. Moreover, the disruption of heterotrimeric
laminin structure by a defective a chain could explain the
semidominant phenotype of both ragged alleles identified
to date.
Several of the LAMA genes have also been mapped to
human chromosomes (summarized in Fig. 11). LAMA1
maps to human 18p11.32-p11.22, LAMA2 to 6q22-q23,
LAMA3 to 18q11.2, and LAMA4 to 6q21. LAMA1 is cur-
rently the only gene that maps to human chromosome 18
and mouse chromosome 17. Thus, LAMA1 defines a new
region of homology between mouse and human chromo-
somes. In contrast, the mouse and human map locations of
LAMA2–4 confirm and extend the known regions of ho-
mology between mouse and human chromosomes (Fig. 11;
data not shown). LAMA5 has not been mapped in hu-
mans. However, the distal region of mouse chromosome 2
shares a region of homology with human chromosome
20q13, suggesting that LAMA5 will map to 20q13 in hu-
mans, as well. As noted in the Introduction, the LAMA2
gene is mutated in some congenital muscular dystrophies,
and the LAMA3 gene is mutated in a subset of patients
with a skin blistering disease, junctional epidermolysis
bullosa. No human mutations that suggest a BL defect map
to the vicinity of the human LAMA1 or LAMA4 locus or
to the predicted LAMA5 locus.
Conclusion
The laminins are major components of BLs throughout
the body, and their a chains are ligands for most cellular
laminin receptors identified to date, including at least six
integrins, dystroglycan, and several glycoconjugates (see
Introduction). Yet the distribution of the laminin a chains
has not previously been studied in detail, and the existence
of the two most recently identified chains (a4 and a5) has
been deduced from cDNA sequence but not shown di-
rectly at the protein level. We have therefore generated a
panel of antibody and cDNA reagents and have used it to
localize the a chain genes on mouse chromosomes and the
a chain RNAs and proteins in developing and adult tissues.
We have also identified a new isoform of laminin a3 and
provided direct evidence for the existence of four novel lami-
nin heterotrimers. Our main conclusions are as follows:
(1) The a subfamily of laminin genes currently consists
of five members, which encode six proteins. Four (a1, a2,
a3B, and a5) are full-sized chains, and two (a3A and a4)
are truncated chains (Fig. 1). The previously hypothesized
mid-sized a chain (a3B) may not, in fact, exist (Fig. 2).
(2) All five of the laminin a chain genes are expressed in
both embryos and adults, but each is expressed in a dis-
tinct pattern (Figs. 3 and 4). Their products are confined to
the extracellular matrix and, with a few exceptions (e.g.,
the glomerular mesangium), to BLs (Fig. 6).
(3) All developing and adult BLs studied to date contain
at least one of the known a chains, and some contain two
or three distinct a chains. Although additional a chains
may well exist, our results provide no evidence for them
and no clues as to their nature or distribution.
(4) Laminin a5 is the most widely distributed a chain in
adult BLs, and a1 is the most restricted. The a2 chain is
particularly abundant in mesodermally derived tissues
(e.g., skeletal and cardiac muscle), and a3 is concentrated
in epithelial BLs. The restricted distribution of a1 is incon-
sistent with the broad distribution of immunoreactive ma-
terial recognized by a widely used mAb, 4C7. This discrep-
ancy, together with data on the distribution of a2–5, raises
the possibility that 4C7 recognizes the a5 chain, in addi-
tion to or instead of a1.
(5) The main patterns of a chain expression are estab-
Figure 11. Chromosomal locations of Lama loci in the mouse
genome, as determined from interspecific backcross analysis. The
number of recombinant N2 animals is presented over the total num-
ber of N2 animals typed to the left of the chromosome maps be-
tween each pair of loci. The recombination frequencies, expressed
as genetic distance in centimorgans (6 one standard error) are
also shown. The upper 95% confidence limit of the recombina-
tion distance is given in parentheses when no recombinants were
found between loci. Gene order was determined by minimizing
the number of recombination events required to explain the al-
lele distribution patterns. The positions of loci on human chro-
mosomes, where known, are shown to the right of the chromo-
some maps. (Asterisk) The human LAMA5 gene is predicted to
reside on chromosome 20q13. References for the human map po-
sitions of loci cited in this study can be obtained from GDB (Ge-
nome Data Base), a computerized database of human linkage in-
formation maintained by The William H. Welch Medical Library
of The Johns Hopkins University (Baltimore, MD).The Journal of Cell Biology, Volume 137, 1997 700
lished embryonically (Fig. 4), but some individual BLs
change in a chain composition as development proceeds.
In kidney, for example, forming glomeruli express three
different a chains in a dynamic progression. Moreover,
distinct portions of a continuous BL, such as that of the
nephron, can contain distinct complements of a chains, and
these change during development as well (Figs. 7 and 8).
(6) Laminins a1–5 all form heterotrimers with b and g
chains. At present, 11 distinct heterotrimers have been
identified in mammalian cells or tissues, including at least
two containing each a chain (Table I). The four heterotri-
mers identified in this study (Fig. 10) have been named
laminins-8 (a4b1g1), -9 (a4b2g1), -10 (a5b1g1), and -11
(a5b2g1).
(7) The five a chain genes are distributed on four chro-
mosomes in mouse, and probably on three chromosomes
in human. The two a chain genes present on a single chro-
mosome in both species (a2 and a4) are not tightly linked,
and two chains present on the same chromosome in hu-
mans (a1 and a3) are on different chromosomes in mouse
(Fig. 11). Thus, there is no evidence for functionally im-
portant linkage of the a chain genes.
The patterns of expression that we have documented in-
dicate that the a chains contribute importantly to the mo-
lecular diversity of BLs. Together with evidence that some
cellular receptors can distinguish among a chains and that
naturally occurring mutations of a2 and a3 have tissue-
specific phenotypes (see Introduction), our results suggest
that differences among a chains are critical to the multi-
plicity of roles that BLs play both during development and
in maturity.
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Note Added in Proof. A third a3 transcript with a distinct 59 end and
translation start site has now been identified by D. Aberdam and col-
leagues. It encodes a protein intermediate in size between the a3B iso-
form reported here and the a3A isoform described by Galliano et al.
(1995). Thus, there may be three isoforms of laminin a3: short (A), full-
length (B), and mid-sized (C) (Aberdam, D., personal communication).
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